Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-12-07
2010-06-29
Gambel, Phillip (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100, C424S141100, C424S158100, C530S387100, C530S388100, C530S388200, C530S388230
Reexamination Certificate
active
07744885
ABSTRACT:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
REFERENCES:
patent: 4603106 (1986-07-01), Cerami et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4822776 (1989-04-01), Cerami et al.
patent: 5075236 (1991-12-01), Yone et al.
patent: 5223395 (1993-06-01), Gero
patent: 5231024 (1993-07-01), Moeller et al.
patent: 5342613 (1994-08-01), Creaven et al.
patent: 5360716 (1994-11-01), Ohmoto et al.
patent: 5436154 (1995-07-01), Barbanti et al.
patent: 5506265 (1996-04-01), Blitstein-Willinger
patent: 5654407 (1997-08-01), Boyle et al.
patent: 5656272 (1997-08-01), Le et al.
patent: 5658570 (1997-08-01), Newman et al.
patent: 5698195 (1997-12-01), Le et al.
patent: 5700788 (1997-12-01), Mongelli et al.
patent: 5730975 (1998-03-01), Hotamisligil et al.
patent: 5741488 (1998-04-01), Feldman et al.
patent: 5750105 (1998-05-01), Newman et al.
patent: 5776947 (1998-07-01), Kroemer et al.
patent: 5874441 (1999-02-01), Magolda et al.
patent: 5888511 (1999-03-01), Skurkovich et al.
patent: 5919452 (1999-07-01), Le et al.
patent: 5958413 (1999-09-01), Anagnostopulos et al.
patent: 5959087 (1999-09-01), Rathjen et al.
patent: 5993833 (1999-11-01), De Lacharriere et al.
patent: 5994510 (1999-11-01), Adair et al.
patent: 6015558 (2000-01-01), Hotamisligil et al.
patent: 6090382 (2000-07-01), Salfeld et al.
patent: 6172202 (2001-01-01), Marcucci et al.
patent: 6190691 (2001-02-01), Mak
patent: 6194451 (2001-02-01), Alpegiani et al.
patent: 6277969 (2001-08-01), Le et al.
patent: 6284471 (2001-09-01), Le et al.
patent: 6309640 (2001-10-01), Cerami et al.
patent: 6419927 (2002-07-01), Cerami et al.
patent: 6790444 (2004-09-01), Le et al.
patent: 6835823 (2004-12-01), Le et al.
patent: 6914128 (2005-07-01), Salfeld et al.
patent: 6991791 (2006-01-01), Le et al.
patent: 7070775 (2006-07-01), Le et al.
patent: 7101674 (2006-09-01), Le et al.
patent: 7128907 (2006-10-01), Le et al.
patent: 7128908 (2006-10-01), Le et al.
patent: 7135178 (2006-11-01), Le et al.
patent: 7135179 (2006-11-01), Le et al.
patent: 7138118 (2006-11-01), Le et al.
patent: 7160542 (2007-01-01), Le et al.
patent: 7160543 (2007-01-01), Le et al.
patent: 7160995 (2007-01-01), Le et al.
patent: 7166284 (2007-01-01), Le et al.
patent: 7169386 (2007-01-01), Le et al.
patent: 7169388 (2007-01-01), Le et al.
patent: 7179466 (2007-02-01), Le etal.
patent: 7179893 (2007-02-01), Le et al.
patent: 7192584 (2007-03-01), Le et al.
patent: 7204985 (2007-04-01), Le et al.
patent: 7214376 (2007-05-01), Le et al.
patent: 7223396 (2007-05-01), Le et al.
patent: 7226593 (2007-06-01), Le et al.
patent: 7227003 (2007-06-01), Le et al.
patent: 7252823 (2007-08-01), Le et al.
patent: 7276239 (2007-10-01), Le et al.
patent: 7335358 (2008-02-01), Le et al.
patent: 7374761 (2008-05-01), Le etal.
patent: 7404955 (2008-07-01), Le et al.
patent: 7416729 (2008-08-01), Le et al.
patent: 7425330 (2008-09-01), Le et al.
patent: 2002/0022720 (2002-02-01), Le et al.
patent: 2002/0114805 (2002-08-01), Le et al.
patent: 2002/0146419 (2002-10-01), Le et al.
patent: 2003/0054004 (2003-03-01), Le et al.
patent: 2003/0147891 (2003-08-01), Le et al.
patent: 2003/0181695 (2003-09-01), Le et al.
patent: 2003/0194402 (2003-10-01), Le et al.
patent: 2004/0115200 (2004-06-01), Le et al.
patent: 2004/0138427 (2004-07-01), Le et al.
patent: 2005/0074454 (2005-04-01), Le et al.
patent: 2005/0249735 (2005-11-01), Le et al.
patent: 2005/0255104 (2005-11-01), Le et al.
patent: 2005/0260201 (2005-11-01), Le et al.
patent: 2006/0018907 (2006-01-01), Le et al.
patent: 2006/0024310 (2006-02-01), Le et al.
patent: 2006/0140946 (2006-06-01), Le et al.
patent: 2006/0140949 (2006-06-01), Le et al.
patent: 2007/0087003 (2007-04-01), Le et al.
patent: 2007/0141057 (2007-06-01), Le et al.
patent: 2007/0196373 (2007-08-01), Le et al.
patent: 2007/0298040 (2007-12-01), Le et al.
patent: 2008/0025976 (2008-01-01), Le et al.
patent: 3631229 (1988-03-01), None
patent: 0 171 496 (1986-02-01), None
patent: 0 184 187 (1986-06-01), None
patent: 0212489 (1987-03-01), None
patent: 0218868 (1987-04-01), None
patent: 0260610 (1988-03-01), None
patent: 0350690 (1990-01-01), None
patent: 0351789 (1990-01-01), None
patent: 0351789 (1990-01-01), None
patent: 0387095 (1990-03-01), None
patent: 0380068 (1990-08-01), None
patent: 0393438 (1990-10-01), None
patent: 0453898 (1991-10-01), None
patent: 0486526 (1992-05-01), None
patent: 0512528 (1992-11-01), None
patent: 0526905 (1993-02-01), None
patent: 0288 088 (1994-03-01), None
patent: 0585705 (1994-03-01), None
patent: 0614984 (1994-09-01), None
patent: 0308378 (1994-11-01), None
patent: 0412486 (1994-11-01), None
patent: 0101681 (1994-12-01), None
patent: 0398327 (1995-03-01), None
patent: 0433900 (1995-09-01), None
patent: 0706795 (1996-04-01), None
patent: 0663836 (1997-07-01), None
patent: 0869179 (1998-10-01), None
patent: 0861850 (2002-05-01), None
patent: 0867509 (2002-08-01), None
patent: 0870827 (2004-03-01), None
patent: 61-047500 (1986-03-01), None
patent: 02-227095 (1990-09-01), None
patent: WO 86/01533 (1986-03-01), None
patent: WO 89/07452 (1989-08-01), None
patent: WO 89/08460 (1989-09-01), None
patent: WO 89/09622 (1989-10-01), None
patent: WO 90/00902 (1990-02-01), None
patent: WO 90/01950 (1990-03-01), None
patent: WO 91/02078 (1991-02-01), None
patent: WO 91/04054 (1991-04-01), None
patent: WO 91/09967 (1991-07-01), None
patent: WO 92/01059 (1992-01-01), None
patent: WO 92/01472 (1992-02-01), None
patent: WO 92/07076 (1992-04-01), None
patent: WO 92/11383 (1992-07-01), None
patent: WO 92/13095 (1992-08-01), None
patent: WO 92/16553 (1992-10-01), None
patent: WO 93/02108 (1993-02-01), None
patent: WO 93/11236 (1993-06-01), None
patent: WO 94/08609 (1994-04-01), None
patent: WO 94/08619 (1994-04-01), None
patent: WO 97/29131 (1997-08-01), None
patent: WO 98/51344 (1998-11-01), None
patent: WO 00/62790 (2000-10-01), None
patent: WO 2004/050683 (2004-06-01), None
patent: WO 2006/065975 (2006-06-01), None
Beutler, B. et al., “Identity of tumour necrosis factor and the macrophage-secreted factor cachectin,”Nature, 316:552-554 (1985).
Beutler, B. et al., “Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin,”Science, 229:869-871 (1985).
Morrison, Sherie L., “Transfectomas Provide Novel Chimeric Antibodies,”Science, 229:1202-1207 (1985).
Liang, Chi-Ming et al., “Production and Characterization of Monoclonal Antibodies Against Recombinant Human Tumor Necrosis Factor/Cachectin,” Biochem. & Biophy. Res. Comm., 137(2):847-854 (1986).
Hirai, Makoto et al., “Production and characterization of monoclonal antibodies to human tumor necrosis factor,”J. of Immun. Methods, 96:57-62 (1987).
Piguet, Pierre-Francois et al., “Tumor Necrosis Factor/Cachectin is an Effector of Skin and Gut Lesions of the Acute Phase of Graft-vs.-Host Disease,”J. Exp. Med., 166:1280-1289 (1987).
Meager, Anthony et al., “Preparation and Characterization of Monoclonal Antibodies Directed Against Antigenic Determinants of Recombinant Human Tumour Necrosis Factor (rTNF),”Hybridoma, 6(3):305-311 (1987).
Fendly, Brian M. et al., “Murine Monoclonal Antibodies Defining Neutralizing Epitopes on Tumor Necrosis Factor,”Hybridoma, 6(4):359-370 (1987).
Bringman, Timothy S. and Aggarwal, Bharat B., “Monoclonal Antibodies to Human Tumor Necrosis Factors Alpha and Beta: Applications for Affinity Purification, Immunoassays, and as Structural Probes,”Hybridoma, 6(5):489-507 (1987).
Tracey, Kevin J. et al., “Anti-cachectin/TNF monoclonal antibodies prevent septic shock during let
Daddona Peter
Ghrayeb John
Knight David
Le Junming
Siegel Scott
Centocor, Inc.
Gambel Phillip
Hamilton Brook Smith & Reynolds P.C.
New York University
LandOfFree
Methods of treating vascular inflammatory pathology using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating vascular inflammatory pathology using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating vascular inflammatory pathology using... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4242920